Andrea van Puffelen

Andrea van Puffelen

The knowledge we gather with WGS can bring us a step closer to our goal to find an effective and suitable treatment for every single patient, not based on ‘one size fits all’, but adjusted to the characteristics of the patient and the tumor.

Back to news

More news

Broader Testing in AYAs Helps 

Broader Testing in AYAs Helps 

15-11-2025

PhD candidates Jeffrey van Putten and Lina Lankhorst investigated whether AYAs (adolescents and young adults, diagnosed with cancer between the ages of …

Hartwig tools now available as a nextflow nf-core pipeline called oncoanalyser 

Hartwig tools now available as a nextflow nf-core pipeline called oncoanalyser 

30-08-2024

The University of Melbourne Centre for Cancer Research (UMCCR) Genomics Platform Group, led by Professor Oliver Hofmann, has collaborated with …

Whole Genome Sequencing feasible in clinical practice

Whole Genome Sequencing feasible in clinical practice

20-09-2020

Interim WIDE analysis gives researchers more confidence in a positive outcome. On 21 September 2020, Dr. Kim Monkhorst, who is a …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl